Skip to main content
. 2020 Aug 11;31(6):2487–2499. doi: 10.1007/s11224-020-01605-w

Fig. 1.

Fig. 1

Computational framework of drug repurposing to identify competitive inhibitors of viral Mpro enzyme to develop newer antiviral therapy against SARS-CoV-2